These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3002046)

  • 21. Evaluation of EIA kits for the detection of HIV antibodies.
    Ovcak S; Drinovec B; Likar M
    Acta Virol; 1987 Sep; 31(5):434-8. PubMed ID: 2891282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Properties and transmission of the AIDS virus].
    Laufs R
    Hautarzt; 1986 May; 37(5):245-9. PubMed ID: 3015839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of serological tests for the detection of HIV-antibodies. The clinical and serological course of one AIDS patient with seroconversion.
    Marth E; Stünzner D; Hengster P; Sixl WD
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(4 Suppl):510-5. PubMed ID: 3327890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The suitability of ELISA for the detection of antibodies against Mycobacterium avium ssp. paratuberculosis in bulk milk samples from Rhineland-Palatinate].
    Geue L; Köhler H; Klawonn W; Dräger K; Hess RG; Conraths FJ
    Berl Munch Tierarztl Wochenschr; 2007; 120(1-2):67-78. PubMed ID: 17290945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of different commercial kits for HIV/HTLV-III EIA.
    Rai A; Kumari S; Prabhakaran PK
    J Commun Dis; 1991 Jun; 23(2):149-53. PubMed ID: 1940222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological survey of HIV infection in the Veneto region of Italy.
    Chieco Bianchi L; Faulkner Valle G; De Rossi A; Dalla Gassa O
    Biomed Pharmacother; 1987; 41(3):139-43. PubMed ID: 3038208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of FIV infection].
    Hartmann K; Kuffer M; Egberink H; Lutz H; Kraft W
    Tierarztl Prax; 1994 Jun; 22(3):268-72. PubMed ID: 8048037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of an expanded two-ELISA approach for confirmation of reactive serum samples in an HIV-screening programme for pregnant women.
    Van Doornum GJ; Buimer M; Gobbers E; Bindels PJ; Coutinho RA
    J Med Virol; 1998 Apr; 54(4):285-90. PubMed ID: 9557294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AIDS: the significance of anti-HTLV-III antibodies.
    Robinson PA; Brough J; Haddy L; Belshe RB; Khakoo R; Stevenson MM
    W V Med J; 1985 Sep; 81(9):194-7. PubMed ID: 2998098
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-HTLV-III testing of blood donors: reproducibility and confirmability of commercial test kits.
    Holland PV; Richards CA; Teghtmeyer JR; Douville CM; Carlson JR; Hinrichs SH; Pedersen NC
    Transfusion; 1985; 25(4):395-7. PubMed ID: 2992129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological diagnosis of human immuno-deficiency virus in Burkina Faso: reliable, practical strategies using less expensive commercial test kits.
    Meda N; Gautier-Charpentier L; Soudré RB; Dahourou H; Ouedraogo-Traoré R; Ouangré A; Bambara A; Kpozehouen A; Sanou H; Valéa D; Ky F; Cartoux M; Barin F; Van de Perre P
    Bull World Health Organ; 1999; 77(9):731-9. PubMed ID: 10534896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Aug; 34(31):477-8. PubMed ID: 2991728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Could saliva be used to detect HIV seroconversion?].
    Sangaré KA; Koffi AR; Coulibaly IM; Doulourou C
    Sante; 1997; 7(5):303-7. PubMed ID: 9480036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliable screening anti HIV with a new ultrasensitive ELISA procedure.
    Krupka U
    Behring Inst Mitt; 1988 Apr; (82):325-37. PubMed ID: 3165635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS serology testing in low- and high-risk groups.
    Carlson JR; Bryant ML; Hinrichs SH; Yamamoto JK; Levy NB; Yee J; Higgins J; Levine AM; Holland P; Gardner MB
    JAMA; 1985 Jun; 253(23):3405-8. PubMed ID: 2987558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of two commercial human immunodeficiency virus serological tests in cases with indeterminate Western blot results.
    Huang LJ; Liu CY; Chu SC; Wong WW; Lin YC; Liu WT; Chan YJ
    J Microbiol Immunol Infect; 2006 Jun; 39(3):219-24. PubMed ID: 16783452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.
    Gürtler LG; Eberle J; Lorbeer B; Deinhardt F
    J Virol Methods; 1987 Jan; 15(1):11-23. PubMed ID: 3468119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.